Targeting tumor vasculature: expanding the potential of DNA cancer vaccines
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting tumor vasculature: expanding the potential of DNA cancer vaccines
Authors
Keywords
Tumor vasculature, Tumor endothelial marker (TEM), DNA cancer vaccine, PIVAC-2014
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 64, Issue 10, Pages 1339-1348
Publisher
Springer Nature
Online
2015-08-12
DOI
10.1007/s00262-015-1747-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microenvironmental regulation of therapeutic response in cancer
- (2015) Florian Klemm et al. TRENDS IN CELL BIOLOGY
- Classification of current anticancer immunotherapies
- (2015) Lorenzo Galluzzi et al. Oncotarget
- Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches
- (2014) Hyun-Jin Choi et al. CANCER AND METASTASIS REVIEWS
- Antibody-based tumor vascular theranostics targeting endosialin/TEM1 in a new mouse tumor vascular model
- (2014) Chunsheng Li et al. CANCER BIOLOGY & THERAPY
- A First-in-Human Phase I Study of MORAb-004, a Monoclonal Antibody to Endosialin in Patients with Advanced Solid Tumors
- (2014) L. A. Diaz et al. CLINICAL CANCER RESEARCH
- Tumor endothelial marker 1–specific DNA vaccination targets tumor vasculature
- (2014) John G. Facciponte et al. JOURNAL OF CLINICAL INVESTIGATION
- Development of 124I Immuno-PET Targeting Tumor Vascular TEM1/Endosialin
- (2014) A.-M. Chacko et al. JOURNAL OF NUCLEAR MEDICINE
- Metronomics: towards personalized chemotherapy?
- (2014) Nicolas André et al. Nature Reviews Clinical Oncology
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chemotherapy Acts as an Adjuvant to Convert the Tumor Microenvironment into a Highly Permissive State for Vaccination-Induced Antitumor Immunity
- (2013) T. H. Kang et al. CANCER RESEARCH
- Influence of tumour micro-environment heterogeneity on therapeutic response
- (2013) Melissa R. Junttila et al. NATURE
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- Antiangiogenic Therapies: Going beyond Their Limits
- (2013) L. Moserle et al. Cancer Discovery
- Generation of more effective cancer vaccines
- (2013) Daniela Fenoglio et al. Human Vaccines & Immunotherapeutics
- The mesenchymal stem cell marker CD248 (endosialin) is a negative regulator of bone formation in mice
- (2012) Amy J. Naylor et al. ARTHRITIS AND RHEUMATISM
- The secret ally: immunostimulation by anticancer drugs
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
- (2011) Andrea Facciabene et al. NATURE
- Cardiovascular Toxicity Profiles of Vascular-Disrupting Agents
- (2011) I. M. Subbiah et al. ONCOLOGIST
- Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice
- (2010) Dhanalakshmi Chinnasamy et al. JOURNAL OF CLINICAL INVESTIGATION
- Rapid isolation of high-affinity human antibodies against the tumor vascular marker Endosialin/TEM1, using a paired yeast-display/secretory scFv library platform
- (2010) Aizhi Zhao et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Early loss of pregnancy after intravitreal bevacizumab injection
- (2009) Petros Petrou et al. ACTA OPHTHALMOLOGICA
- Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytes
- (2009) S. Ugel et al. BLOOD
- Characterization of TEM1/endosialinin human and murine brain tumors
- (2009) Eleanor B Carson-Walter et al. BMC CANCER
- Therapeutic targeting of myeloid-derived suppressor cells
- (2009) Stefano Ugel et al. CURRENT OPINION IN PHARMACOLOGY
- Endosialin (Tem1) Is a Marker of Tumor-Associated Myofibroblasts and Tumor Vessel-Associated Mural Cells
- (2008) Sven Christian et al. AMERICAN JOURNAL OF PATHOLOGY
- Preventive Vaccination with Telomerase Controls Tumor Growth in Genetically Engineered and Carcinogen-Induced Mouse Models of Cancer
- (2008) C. Mennuni et al. CANCER RESEARCH
- Endosialin Protein Expression and Therapeutic Target Potential in Human Solid Tumors: Sarcoma versus Carcinoma
- (2008) C. Rouleau et al. CLINICAL CANCER RESEARCH
- The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer
- (2008) Alexandra Giatromanolaki et al. GYNECOLOGIC ONCOLOGY
- Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248
- (2008) R. G. Bagley et al. MOLECULAR CANCER THERAPEUTICS
- Age-dependent tolerance to an endogenous tumor-associated antigen
- (2008) Jennifer A. McWilliams et al. VACCINE
- Angiogenesis as a strategic target for ovarian cancer therapy
- (2008) Whitney A Spannuth et al. Nature clinical practice. Oncology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started